Yahoo Web Search

Search results

    • Investing in Taysha Gene Therapies Inc

      Knox Daily· 6 days ago

      Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published on April 09, 2024; the price target was $9. A number of analysts ...